Trial intelligence / Profile preview

Valdecoxib vs Piroxicam in Primary Dysmenorrhea

NCT00649415Phase 4Completed

Sponsor
Pfizer
Start
Jan 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of valdecoxib in primary dysmenorrhea (PD), sponsored by Pfizer. Started Jan 2003; status: completed.

02

Drugs

valdecoxib
03

Conditions

primary dysmenorrhea (PD)

Beyond the preview

Go deeper on NCT00649415.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00649415.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call